Some viruses help drug-resistant bacteria grow in the lungs of cystic fibrosis patients, new Stanford research shows.
By scouting for a particular immune cell in the blood, scientists can tell which patients with a lung-scarring disease are at higher risk for death.
What makes breathing possible is a thin coating of a soaplike film, or surfactant, that lowers the tension of the lung’s inner surface. Premature babies and adults with lung injuries are short on surfactant, and replacing it has been prohibitively pricey. That may be about to change.
This Stars of Stanford Medicine Q&A features Kristina Kudelko, who specializes in pulmonary hypertension. She also runs, loves music and spending time with her family.
When I mention to people that I had a double lung transplant, they usually react in one of two ways. They're likely to say, “Wow, …